Pharming Group NV News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.12.20	Pharming announces enrolment of first patient in US clinical trial for the treatment of COVID-19 with RUCONEST® (PR Newswire)
26.11.20	Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ordinary Shares on Nasdaq Global Market (PR Newswire)
23.11.20	Juergen Ernst to retire from Pharming's Board of Supervisory Directors after more than 11 years of distinguished service (PR Newswire)
19.11.20	Pharming announces commitment to build a new downstream manufacturing facility for RUCONEST® (PR Newswire)
09.11.20	Pharming appoints Jeroen Wakkerman as Chief Financial Officer (PR Newswire)
29.10.20	Pharming Group reports financial results for the first nine months of 2020 (PR Newswire)
29.10.20	Pharming convenes Extraordinary General Meeting of shareholders (PR Newswire)
21.10.20	Pharming receives Orphan Drug Designation from the European Commission for leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS) (PR Newswire)
17.08.20	Pharming announces the publication of data from a compassionate use programme of RUCONEST® in COVID-19 patients in a peer-reviewed journal (PR Newswire)
10.08.20	Pharming announces enrolment of first patient in multinational clinical trial for the treatment of COVID-19 with RUCONEST® (PR Newswire)
30.07.20	Pharming Group reports financial results for the first half of 2020 (PR Newswire)
20.05.20	Pharming Reports on Annual General Meeting of Shareholders (PR Newswire)
20.05.20	Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors (PR Newswire)
14.05.20	Pharming Group Reports Financial Results for the First Quarter of 2020 (PR Newswire)
21.04.20	Pharming Reports Encouraging Results From Use of RUCONEST® in COVID-19 Patients (PR Newswire)
08.04.20	Pharming Group Convenes Annual General Meeting of Shareholders (PR Newswire)
23.03.20	Pharming Enters the Euronext Amsterdam Midkap-index (AMX) (PR Newswire)
11.03.20	Pharming CFO to Step Down (PR Newswire)
09.03.20	Pharming Receives FDA Approval of New Facility for Expansion of RUCONEST® Production (PR Newswire)
05.03.20	Pharming Group Reports Strong Preliminary (Unaudited) Financial Results for 2019 (PR Newswire)
21.01.20	Pharming Receives EMA Approval of New Facility for Expansion of RUCONEST® Production (PR Newswire)
14.01.20	Pharming Announces the Placement of €125 Million Senior Unsecured Convertible Bonds Due 2025 (PR Newswire)
30.12.19	Pharming Reacquires RUCONEST®-licensed Territories from Sobi (PR Newswire)
24.10.19	Pharming Group Reports Strong Interim Financial Results for the First Nine Months of 2019 (PR Newswire)
13.08.19	Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS (PR Newswire)
22.05.19	Pharming Reports on Annual General Meeting of Shareholders (PR Newswire)
16.05.19	Pharming Today Celebrates "hae day :-)" - The Global Awareness Day for Hereditary Angioedema, a Rare Life-threatening Condition (PR Newswire)
16.05.19	Pharming Group Reports Interim Financial Results for the First Quarter of 2019 (PR Newswire)
10.04.19	Pharming Group Announces Notice to Convene to Annual General Meeting of Shareholders (PR Newswire)
29.03.19	Pharming Group Announces Publication of Its Annual Report 2018 and a Provisional Commitment to Invest in Supplier (PR Newswire)
07.03.19	Pharming Group Reports Strong Preliminary Financial Results for 2018 Including First Year of Net Profit (PR Newswire)
25.02.19	Pharming Announces Abstract Presented at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and Sponsorship of the AAAAI Foundation Michael M. Frank, MD, FAAAI Lectureship (PR Newswire)
23.01.19	Pharming Announces Abstracts Presented at The Western Society of Allergy, Asthma & Immunology (WSAAI) Conference This Week (PR Newswire)
07.12.18	Pharming Reports Favourable Conclusion from First Investigator-initiated Direct Comparative Real-world Study of Acute Hereditary Angioedema Therapies (PR Newswire)
25.10.18	Pharming Group Reports Interim Financial Results for the First Nine Months of 2018 (PR Newswire)
17.10.18	Pharming Reports Positive Data From First Investigator-initiated Study of rhC1-Inhibitor (RUCONEST®) in Contrast-induced Nephropathy (PR Newswire)
19.09.18	Pharming Receives Complete Response Letter from FDA (PR Newswire)
30.07.18	Pharming Announces Further Issue of Shares as Employee Options Are Exercised (PR Newswire)
26.07.18	Pharming Reports on Financial Results for the First Half of 2018 (PR Newswire)
06.03.14	Pharming Reports On Preliminary Financial Results 2013 (GlobeNewswire)
24.02.14	PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST® (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Pharming Group NV

Aktien Top/Flop

Meistgelesene Nachrichten